Please login to the form below

KKR

This page shows the latest KKR news and features for those working in and with pharma, biotech and healthcare.

Investment firm pays $2.8bn for WebMD

KKR will roll WebMD into its Internet Brands subsidiary, a leading web hosting and software-as-a-service (SaaS) company that works in a number of sectors, including health. ... In the end the process saw WebMD “outreach to more than 100 strategic and

Latest news

Bayer sells diabetes division to Panasonic Healthcare

Sales of the divested products lines were 909m last year, and Panasonic - which is majority-owned by private equity group KKR - says gaining full control will allow it to improve growth ... We are confident that the sale of our diabetes-care business to
GSK plans to sell off older products

conference. Among the firms given the opportunity to view the portfolio are Advent International, Blackstone and KKR, according to Reuters, which indicated the overture was initially revealed by Sky News.
KKR acquires clinical trials firm PRA International

US clinical research organisation (CRO) PRA International has been acquired for an undisclosed sum by global investment firm KKR. ... KKR has a long history in healthcare, having invested more than $9bn in the sector since 1995.
Capsugel expands its product portfolio

The New Jersey company, which Pfizer sold for $2.4bn in 2011 to investment firm KKR, has announced the launched of its Dosage Form Solutions (DFS) unit.
Pfizer sells Capsugel business for $2.4bn

KKR, a leading global investment firm, manages assets through a variety of investment funds and accounts. ... As of December 31, 2010, KKR had $61bn in assets under its management.

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Deal Watch - May 2017

go. Barbarians at the Gate. “Barbarians at the Gate” is the title of a book describing the battle for control of RJR Nabisco in 1988 between KKR, a leveraged buyout firm ... KKR won the battle and were accused of being Barbarians for loading RJR
Deal Watch table for September 2013

700. Gland Pharma / KKR. Acquisition (40 per cent). Indian generics company.
Pharma deals during September 2013

Similar concerns are faced by Indian authorities as KKR has announced its intention to acquire 40 pre cent of generics company Gland Pharma for around $500m.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Client Services Director- Flexible Working: Negotiable

Events Executive: DOE

Account Director – UK Office: Excellent salary and benefits

Account Manager – Healthcare advertising: Salary TBC

Senior Medical Writer: Competitive salary plus benefits

Subscribe to our email news alerts

PMHub

Add my company

Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...